About Me
My goal as an interventional cardiologist is to improve the lives of people who have complex coronary artery disease. This includes people with severely blocked or narrowed arteries and chronic total occlusion, which occurs when an artery is completely blocked for three or more months.
I also specialize in using angioplasty to open blocked coronary arteries for people who have chronic kidney disease. Coronary angioplasty generally relies on the use of contrast dye to makes blockages visible. However, for people with chronic kidney disease the dye can further worsen kidney function and increase the chance of needing dialysis. To limit the impact on kidney function, I use as little dye as possible, and sometimes none at all.
When I meet with patients, I want to understand their individual needs. I discuss their symptoms and test results and ask how the heart condition is affecting their everyday lives, because treatment for blocked arteries is not a one-size-fits-all endeavor. I strive to determine the treatment that is most likely to improve a person’s quality of life in the least invasive way.
I use advanced stenting technology and best-in-class stents. My treatment recommendations are based on evidence from clinical studies and national and international society practice guidelines, many of which I participate in. Ultimately, my goal is to determine the treatment plan that is most likely to result in the best short- and long-term outcomes for my patients.
I am actively involved in research comparing the effectiveness of different cardiovascular disease treatments, including medication and stenting. I am the principal investigator of the ISCHEMIA-CKD trial, a randomized trial for patients with advanced chronic kidney disease and abnormal stress test, which is being carried out in 33 countries and up to 350 clinical sites. The trial tests the effectiveness of performing cardiac catheterization versus medical therapy alone for people who have chronic kidney disease. In addition, my research has compared the outcomes of stenting versus coronary bypass graft surgery for people with multiple blockages.
I have received several awards including the Dr. Gregory Braden Memorial Fellow of the Year Award from the Society for Cardiovascular Angiography and Interventions and the Douglas P. Zipes Distinguished Young Scientist Award from the American College of Cardiology. I have been awarded grants from the National Institutes of Health, Agency for Healthcare Research and Quality, and American Heart Association, as well as from the industry, and have published more than 400 articles in leading national and international journals.
Conditions and Treatments
Conditions
- abnormal heart rhythms
- acute coronary syndrome
- angina
- aortic valve disease
- aortic valve insufficiency
- aortic valve stenosis
- aortoiliac occlusive disease
- arteriosclerosis
- carotid artery disease
- carotid stenosis
- chest pain
- claudication
- congestive heart failure
- coronary artery disease
- critical limb ischemia
- heart attack
- heart disease
- heart muscle disease
- high blood pressure
- inflammation of the heart valve
- mitral valve regurgitation
- mitral valve stenosis
- peripheral vascular disease
- renal artery stenosis
Treatments
- cardiac catheterization
Learn more about conditions we treat at NYU Langone:
Aortic Valve Disease , Aortoiliac Occlusive Disease , Carotid Artery Disease , Coronary Artery Disease , High Blood Pressure , Renal Artery StenosisCredentials
Positions
- Professor, Department of Medicine at NYU Grossman School of Medicine
- Director, Research, Cardiac Catheterization Lab
- Director, Cardiac Catheterization Laboratory, Bellevue Hospital
Board Certifications
- American Board of Internal Medicine (Interventional Cardiology), 2009
- American Board of Internal Medicine (Cardiovascular Disease), 2008
Education and Training
- Fellowship, Peter Bent Brigham Hospital, Interventional Cardiology, 2010
- Fellowship, Mount Sinai (St. Luke's-Roosevelt Hospital Center), Cardiovascular Med, 2008
- MD from Bangalore University, 2000
Is this your profile?
Edit profileInsurance Plans Accepted
This provider accepts the following insurance plans.
-
Aetna
- Aetna HMO
- Aetna Medicare
- Aetna POS
- Aetna PPO/EPO
-
Agewell
- Agewell
-
Amidacare
- Amidacare
-
Blue Cross Blue Shield
- Empire BCBS
- Empire BCBS Top Tier
-
Centerlight
- Centerlight
-
Centers Plan For Healthy Living
- Centers Plan for Healthy Living
-
Cigna
- Cigna EPO/POS
- Cigna PPO
-
ElderPlan
- ElderPlan
-
Emblem
- Emblem Select Care Exchange
-
Empire Blue Cross Blue Shield
- Empire Blue Cross Blue Shield EPO
- Empire Blue Cross Blue Shield HMO
- Empire Blue Cross Blue Shield HealthPlus
- Empire Blue Cross Blue Shield Indemnity
- Empire Blue Cross Blue Shield MediBlue
- Empire Blue Cross Blue Shield POS
- Empire Blue Cross Blue Shield PPO
-
Fidelis
- Fidelis Child Health
- Fidelis Exchange
- Fidelis Medicaid
- Fidelis Medicare
-
GHI
- GHI CBP
- GHI HMO
-
HIP
- HIP Access I
- HIP Access II
- HIP Child Health
- HIP EPO/PPO
- HIP HMO
- HIP Medicaid
- HIP Medicare
- HIP POS
-
Hamaspik Choice
- Hamaspik Choice Medicare DSNP
-
Healthfirst
- Healthfirst
-
Hotel Trades
- Hotel Trades
-
Humana
- Humana Medicare
-
Local 1199
- Local 1199 PPO
-
Longevity Health Plan
- Longevity Health Plan Medicare
-
MagnaCare
- MagnaCare PPO
-
Medicaid
- NY Medicaid
-
Medicare
- Medicare
-
MetroPlus
- MetroPlus Child Health
- MetroPlus Exchange Plans
- MetroPlus Medicaid
- MetroPlus Medicare
-
MultiPlan/PHCS
- MultiPlan/PHCS PPO
-
NYS Health Insurance Plan
- The Empire Plan
-
Oxford
- Oxford Freedom
- Oxford Liberty
- Oxford Medicare
-
Railroad Medicare
- Railroad Medicare
-
River Spring Health Plan
- River Spring Medicare HMP SNP
-
Senior Whole Health
- Senior Whole Health
-
Tricare
- Tricare
-
UHC
- UnitedHealthcare EPO
- UnitedHealthcare HMO
- UnitedHealthcare Medicare
- UnitedHealthcare POS
- UnitedHealthcare PPO
- UnitedHealthcare Top Tier
-
VNS
- Visiting Nurse Service (VNS) Medicare
-
Village Caremax
- Village Caremax
-
WTC Health Program
- WTC Health Program
-
WellCare
- WellCare Medicare
Sripal Bangalore, MD does not accept insurance.
Locations and Appointments
NYU Langone Cardiac Catheterization Associates
550 First Avenue, 14th Floor, New York, NY 10016
Research My Research
Research Summary
Dr. Bangalore is the PI of a multicenter, international, randomized controlled trial conducted to define the role of an invasive approach in patients with stable ischemic heart disease and substantial ischemia and chronic kidney disease (eGFR <30 or on dialysis). Patients with advanced CKD and moderate to severe ischemia on stress testing will be randomized to INV strategy of cath with optimal revascularization along with optimal medical therapy or to a CON strategy of optimal medical therapy alone with cath reserved for OMT failure. View the clinical trial.
In addition, his research interests are in comparative effectiveness studies for cardiovascular diseases, particularly stable ischemic heart disease, acute coronary syndromes, hypertension and dyslipidemia. Dr. Bangalore has received grants from the National Institutes of Health, Agency for Healthcare Research and Quality, American Heart Association and from the industry.
Research Interests Timeline
Clinical Trials and Research Studies
-
STRIKE-PE: A Prospective Multicenter Study of the IndigoTM Aspiration System Seeking to Evaluate the Long-Term Safety and Outcomes of Treating Pulmonary Embolism
-
Heart Attack Research Program (HARP)
-
Impella -Supported PCI in High-Risk Patients with Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
Publications
-
Venoarterial extracorporeal membrane oxygenation in high-risk pulmonary embolism: A narrative review
Yuriditsky, Eugene; Bakker, Jan; Alviar, Carlos L; Bangalore, Sripal; Horowitz, James MJournal of critical care. 2024 Dec ; 84:154891
-
Bangalore, Sripal; Maqsood, Muhammad H
European heart journal. 2024 Nov 15;
-
Bangalore, Sripal; Maqsood, Muhammad H
European heart journal. 2024 Nov 15;